Announce Date | 03/05/2025 |
EPS Normalized Actual | $1.74 (Beat by $0.16) |
EPS GAAP Actual | $1.74 (Beat by $0.16) |
Revenue Actual | $0.720886B |
Revenue Surprise | Beat by $720.886M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Jan 2030 | 12.505 | 17.43 | 12.2456 | 12.81558 | 2 |
Jan 2029 | 10.48 | 20.8 | 10.29751 | 10.65185 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Jan 2025) | 1.2 | 1.2 | 0.720886B | 12.52% | 720.89M |
FQ4 2024 (Oct 2024) | 1.15 | 1.15 | 0.699207B | 11.83% | 699.21M |
FQ3 2024 (Jul 2024) | 1.06 | 1.06 | 0.676181B | 12.71% | 676.18M |
FQ2 2024 (Apr 2024) | 1 | 1 | 0.650345B | 19.07% | 650.35M |
FQ1 2024 (Jan 2024) | 0.9 | 0.9 | 0.630618B | 10.66% | 630.62M |
FQ4 2023 (Oct 2023) | 0.84 | 0.84 | 0.616505B | 10.41% | 616.51M |
FQ3 2023 (Jul 2023) | 0.7 | 0.7 | 0.590225B | 9.49% | 590.23M |
FQ2 2023 (Apr 2023) | 0.82 | 0.82 | 0.526325B | 100% | 526.33M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 2.42515 | -- | 2.40827 | 2.44135 | 12 |
FQ3 2027 (Jul 2027) | 2.32436 | -- | 2.30818 | 2.33989 | 12 |
FQ2 2027 (Apr 2027) | 2.23549 | -- | 2.21995 | 2.25044 | 11 |
FQ1 2027 (Jan 2027) | 2.06211 | -- | 2.03113 | 2.07828 | 13 |
FQ4 2026 (Oct 2026) | 2.06492 | -- | 2.04197 | 2.08448 | 6 |
FQ3 2026 (Jul 2026) | 1.90447 | -- | 1.88331 | 1.92251 | 6 |
FQ2 2026 (Apr 2026) | 1.64743 | -- | 1.62912 | 1.66304 | 6 |
FQ1 2026 (Jan 2026) | 1.78231 | 32.67 | 1.75554 | 1.79628 | 6 |
FQ4 2025 (Oct 2025) | 1.63223 | 29.54 | 1.61409 | 1.64769 | 10 |
FQ3 2025 (Jul 2025) | 1.54981 | 31.6 | 1.53259 | 1.56449 | 10 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 1B | -- | 0.99B | 1B | 12 |
FQ3 2027 (Jul 2027) | 0.96B | -- | 0.96B | 0.97B | 18 |
FQ2 2027 (Apr 2027) | 0.93B | -- | 0.92B | 0.93B | 11 |
FQ1 2027 (Jan 2027) | 0.9B | -- | 0.89B | 0.91B | 9 |
FQ4 2026 (Oct 2026) | 0.94B | -- | 0.93B | 0.94B | 7 |
FQ3 2026 (Jul 2026) | 0.9B | -- | 0.89B | 0.91B | 7 |
FQ2 2026 (Apr 2026) | 0.85B | -- | 0.84B | 0.85B | 7 |
FQ1 2026 (Jan 2026) | 0.8B | 9.5 | 0.79B | 0.8B | 6 |
FQ4 2025 (Oct 2025) | 0.81B | 13.18 | 0.8B | 0.81B | 9 |
FQ3 2025 (Jul 2025) | 0.78B | 13.12 | 0.77B | 0.78B | 9 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Jan 2025) | 1.2 | 1.2 | 100% | |
FQ4 2024 (Oct 2024) | 1.15 | 1.15 | 100% | |
FQ3 2024 (Jul 2024) | 1.06 | 1.06 | 100% | |
FQ2 2024 (Apr 2024) | 1 | 1 | 100% | |
FQ1 2024 (Jan 2024) | 0.9 | 0.9 | 100% | |
FQ4 2023 (Oct 2023) | 0.84 | 0.84 | 100% | |
FQ3 2023 (Jul 2023) | 0.7 | 0.7 | 100% | |
FQ2 2023 (Apr 2023) | 0.82 | 0.82 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Jan 2025) | $0B | $0.72B | $720.89M | 100% |
FQ4 2024 (Oct 2024) | $0B | $0.7B | $699.21M | 100% |
FQ3 2024 (Jul 2024) | $0B | $0.68B | $676.18M | 100% |
FQ2 2024 (Apr 2024) | $0B | $0.65B | $650.35M | 100% |
FQ1 2024 (Jan 2024) | $0B | $0.63B | $630.62M | 100% |
FQ4 2023 (Oct 2023) | $0B | $0.62B | $616.51M | 100% |
FQ3 2023 (Jul 2023) | $0B | $0.59B | $590.23M | 100% |
FQ2 2023 (Apr 2023) | $0B | $0.53B | $526.33M | 100% |